These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 32988769)
1. A tool to measure the economic impact of Hepatitis B elimination: A case study in Saudi Arabia. Sanai FM; Alghamdi M; Dugan E; Alalwan A; Al-Hamoudi W; Abaalkhail F; AlMasri N; Razavi-Shearer D; Razavi H; Schmelzer J; Alfaleh FZ J Infect Public Health; 2020 Nov; 13(11):1715-1723. PubMed ID: 32988769 [TBL] [Abstract][Full Text] [Related]
3. The current and future burden of hepatitis B in Switzerland: a modelling study. Negro F; Müllhaupt B; Semela D; Blach S; Bruggmann P; De Gottardi A; Dufour JF; Fraga M; Galante A; Razavi H; Vieira Barbosa J; Razavi-Shearer D Swiss Med Wkly; 2023 Jun; 153():40086. PubMed ID: 37410921 [TBL] [Abstract][Full Text] [Related]
4. Epidemiology, disease burden, and treatment strategies of chronic hepatitis C virus infections in Saudi Arabia in the new treatment paradigm shift. Aljumah AA; Abaalkhail F; Al-Ashgar H; Assiri A; Babatin M; Al Faleh F; Alghamdi A; Al-Hakeem R; Hashim A; Alqutub A; Razavi H; Sanai FM; Al-Swat K; Schmelzer J; Altraif I Saudi J Gastroenterol; 2016; 22(4):269-81. PubMed ID: 27488321 [TBL] [Abstract][Full Text] [Related]
5. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends. Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis B vaccination in children: the Taiwan experience. Ni YH; Chen DS Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181 [TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma in Saudi Arabia: role of hepatitis B and C infection. Ayoola EA; Gadour MO J Gastroenterol Hepatol; 2004 Jun; 19(6):665-9. PubMed ID: 15151622 [TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of strategies to manage the disease burden of hepatitis C virus in Switzerland. Blach S; Schaetti C; Bruggmann P; Negro F; Razavi H Swiss Med Wkly; 2019 Mar; 149():w20026. PubMed ID: 30905063 [TBL] [Abstract][Full Text] [Related]
9. High Level of Hepatitis B Core-Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load. Tseng TC; Liu CJ; Hsu CY; Hong CM; Su TH; Yang WT; Chen CL; Yang HC; Huang YT; Fang-Tzu Kuo S; Liu CH; Chen PJ; Chen DS; Kao JH Gastroenterology; 2019 Dec; 157(6):1518-1529.e3. PubMed ID: 31470004 [TBL] [Abstract][Full Text] [Related]
10. Review article: the prevention of hepatitis B-related hepatocellular carcinoma. Lin CL; Kao JH Aliment Pharmacol Ther; 2018 Jul; 48(1):5-14. PubMed ID: 29722445 [TBL] [Abstract][Full Text] [Related]
11. Disease burden of chronic hepatitis B and complications in China from 2006 to 2050: an individual-based modeling study. Zheng Y; Wu J; Ding C; Xu K; Yang S; Li L Virol J; 2020 Aug; 17(1):132. PubMed ID: 32859216 [TBL] [Abstract][Full Text] [Related]
12. Seroepidemiology of hepatitis B virus infection in Saudi Arabian children: a baseline survey for mass vaccination against hepatitis B. al-Faleh FZ; Ayoola EA; Arif M; Ramia S; al-Rashed R; al-Jeffry M; al-Mofarreh M; al-Karawi M; al-Shabrawy M J Infect; 1992 Mar; 24(2):197-206. PubMed ID: 1533236 [TBL] [Abstract][Full Text] [Related]
13. NIH consensus development statement on management of hepatitis B. Belongia EA; Costa J; Gareen IF; Grem JL; Inadomi JM; Kern ER; McHugh JA; Petersen GM; Rein MF; Sorrell MF; Strader DB; Trotter HT NIH Consens State Sci Statements; 2008 Oct 22-24; 25(2):1-29. PubMed ID: 18949020 [TBL] [Abstract][Full Text] [Related]
14. Scenarios to manage the hepatitis C disease burden and associated economic impact of treatment in Turkey. Örmeci N; Malhan S; Balık İ; Ergör G; Razavi H; Robbins S Hepatol Int; 2017 Nov; 11(6):509-516. PubMed ID: 29027109 [TBL] [Abstract][Full Text] [Related]
15. [Hepatocellular carcinoma, hepatitis B virus and the immune system]. Grob PJ Schweiz Med Wochenschr; 1986 Aug; 116(34):1133-45. PubMed ID: 3020684 [TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness of Testing and Treatment for Hepatitis B Virus and Hepatitis C Virus Infections: An Analysis by Scenarios, Regions, and Income. Tordrup D; Hutin Y; Stenberg K; Lauer JA; Hutton DW; Toy M; Scott N; Chhatwal J; Ball A Value Health; 2020 Dec; 23(12):1552-1560. PubMed ID: 33248510 [TBL] [Abstract][Full Text] [Related]
17. Direct economic burden of hepatitis B virus related diseases: evidence from Shandong, China. Lu J; Xu A; Wang J; Zhang L; Song L; Li R; Zhang S; Zhuang G; Lu M BMC Health Serv Res; 2013 Jan; 13():37. PubMed ID: 23368750 [TBL] [Abstract][Full Text] [Related]
18. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence. Hung HF; Chen TH Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755 [TBL] [Abstract][Full Text] [Related]
19. Immunization programme against hepatitis B virus infection in Italy: cost-effectiveness. Da Villa G; Sepe A Vaccine; 1999 Mar; 17(13-14):1734-8. PubMed ID: 10194831 [TBL] [Abstract][Full Text] [Related]
20. The decline of hepatitis B viral infection in South-Western Saudi Arabia. Ayoola AE; Tobaigy MS; Gadour MO; Ahmad BS; Hamza MK; Ageel AM Saudi Med J; 2003 Sep; 24(9):991-5. PubMed ID: 12973485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]